INDIAN PHARMACOPOEIA 2007 - ajprd

383 Pages·2008·2.52 MB·English

INDIAN
PHARMACOPOEIA
2007
Volume 1
THE INDIAN PHARMACOPOEIA COMMISSION
GHAZIABAD
ISBN 81-903436-0-3
© 2007, Indian Pharmacopoeia Commission
Application for reproduction should be made to the INDIAN PHARMACOPOEIA COMMISSION
Sector-23, Raj Nagar,
Ghaziabad-201 002
India
Tale: (91-120) – 2783401
Fax: (91-120) – 2783311
Web-site: www.ipc.gov.in E.mail: [email protected]
Effective from 31st March 2008
On behalf of : GOVERNMENT OF INDIA
MINISTRY OF HEALTH & FAMILY WELFARE
Designed, produced & published by : THE INDIAN PHARMACOPOEIA COMMISSION
CENTRAL INDIAN PHARMACOPOEIA LABORATORY
GOVT. OF INDIA, MINISTRY OF HEALTH & FAMILY WELFARE
SECTOR-23, RAJ NAGAR, GHAZIABAD-201 002.
Printed by : NATIONAL INSTITUTE OF SCIENCE COMMUNICATION
AND INFORMATION RESOURCES (NISCAIR)
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
PUSA GATE, K. S. KRISHNAN MARG, NEW DELHI – 110012
Price: Inland Rs 25000.00
Foreign - $ 1000.00
£ 500.00
IP 2007 NOTICES
Notices
Legal Notices Scientific Director is authorised to issue such amendments.
Whenever such amendments are issued, the Indian
In India, under the Drugs and Cosmetics Act 1940, the current
Pharmacopoeia would be deemed to have been amended
edition of Indian Pharmacopoeia is a book of standards for
accordingly.
drugs included therein and the standards as included in the
Indian Pharmacopoeia would be official. Also, in several other
Patents And Trade Marks
laws of India, the Indian Pharmacopoeia is recognised as the
standard book. It is expedient that enquiry be made in each In the Indian Pharmacopoeia, certain drugs and preparations
case in order to ensure that the provisions of any such law are have been included notwithstanding the existence of actual
being complied with. In general, the Drugs and Cosmetics or potential rights in any part of the world. In so far as such
Act, 1940, the Narcotic Drugs and Psychotropic Substances substances are protected by Letters Patent their inclusion in
Act, 1985, the Poisons Act, 1919 and the rules framed the Indian Pharmacopoeia neither conveys, nor implies, licence
thereunder should be consulted. These statutes empower the to manufacture without due permission, authority, or licence
Government agencies to enforce the law using this from the person or persons in whom such rights exist.
compendium. The monographs of the Indian Pharmacopoeia
The titles given under the individual monographs are public
should be read subject to the restriction imposed by those
property. These titles cannot be patented as trade marks and
laws which are applicable.
no person is permitted to patent any trade mark devising the
If considered necessary, the standards included in Indian root of these titles.
Pharmacopoeia can be amended and the Secretary-cum-
v
IP 2007 PREFACE
Preface
The Indian Pharmacopoeia 2007 is published by the Indian technology and experimental methods widely adopted in India
Pharmacopoeia Commission (IPC) on behalf of the Government and abroad are being added and updated. The contents of
of India, Ministry of Health & Family Welfare. The Government Appendices are revised by and large in consonance with those
of India constituted the IPC vide their Order No. Z-14012/IPC/ nowadays adopted internationally for monitoring the quality
CBP/ 2003 dated 22nd March 2005. The IPC is a Society under of the drugs. The monographs of special relevance to the
the provisions of the Societies Registration Act, 1860 (Act common disease pattern of this region have been given special
No. 21 of 1860) for the registration of Literary, Scientific and emphasis by incorporating such medicines.
Charitable Societies. The functioning of the Commission is In addition, emphasis has been put to bring out harmonisation
governed by the provisions of the approved Memorandum of in Appendices to a sound connection between individual
Association, Rules and Regulations of the IPC. monographs and the relevant appendices, and to the
The Commission has set up its headquarters in the campus of standardization of text wording so as to make this edition
the Central Indian Pharmacopoeia Laboratory (CIPL), Sector- precise and well structured. The number of monographs in
23, Raj Nagar, Ghaziabad, UP. The Director CIPL, also Appendices are expanded further to incorporate the latest
functions as the Secretary-cum-Scientific Director of the IPC. technological advances and complies with regulatory
The CIPL is the support structure of the Commission. requirements. Great efforts have been made to unify the
National Drug Standards and to bring them in line with the
The Indian Pharmacopoeia is being produced in fulfillment of
International Standards progressively by addition of
the requirement in the Drugs and Cosmetics Rules, 1945 of
monographs of new drugs and current methodology adopted.
standards of drugs produced in India and in the belief that it
contributes significantly in the control of the quality of Public Review and Comment Process for Standards Develop-
medicinal products. The standards of this pharmacopoeia are ment Related to this edition of the Indian Pharmacopoeia have
legally enforceable and are intended to help in the licensing been given special attention to incorporate comments from
and inspection processes. stakeholders as shown below:
After independence an Indian Pharmacopoeia Committee was
constituted in 1948, which prepared the Pharmacopoeia of
India (The Indian Pharmacopoeia) 1955. A Supplement to it
was published in 1960. This pharmacopoeia contained western
and also traditional drugs, and the same policy continued
while preparing the Pharmacopoeia of India 1966 and its 1975
Supplement. In the Pharmacopoeia of India 1985 and its
Addenda 1989 and 1991, traditional drugs were not included
as publication of a pharmacopoeia of traditional system drugs
was taken up separately and only those herbal drugs were
included which had supporting definitive quality control
standards.
In the period since the publication of the 1985 Edition there
has been a significant increase in the range of drugs produced
in India. Keeping this in mind the Committee has deleted or
added monographs on a system of priorities based on the
medical merit and the extent of use of any given article in the
country in its following 1996 Edition and its addenda in 2000,
2002, 2005 and one supplement for Veterninary Products in 2002.
The Indian Pharmacopoeia 2007 has been prepared in
accordance with the principles and designed plan decided by
the Scientific Body of the Indian Pharmacopoeia Commission
and completed with untiring efforts made by Commission
members and its Secretariat over almost two years.
The Indian Pharmacopoeia 2007 is presented on the user
friendly format. The General Notices, Monographs and new
testing methods, etc. based on the introduction of advanced
vii
PREFACE IP 2007
In addition to the traditional way of requesting for comments, adopts new style of formatting. The improvement of quality in
the contents of revised appendices and monographs have printing and binding makes this edition look more elegant.
been publicized on the website of the Indian Pharmacopoeia The Indian Pharmacopoeia 2007 is published in three volumes.
Commission, aiming at collecting comments widely from It is presumed that the Pharmacopoeia would play a vital role
various institutions and organizations. All the feedbacks and in initiating new prospect for improving the quality of medicines
inputs have been reviewed by the relevant Expert Committee and would also help to accelerate development of Pharma
to ensure the feasibility and practicability of the standards Sector.
and methods revised in this edition of Pharmacopoeia, and
The Commission places on record its appreciation of the
ensure that the principle of “openness, justice and fairness”
services of all the persons who have contributed to the
is kept in the process of compiling and editing.
production of this compendium.
In order to make it easy for reading, understanding and
interpreting the content of the Indian Pharmacopoeia 2007
viii
IP 2007 INDIAN PHARMACOPOEIA COMMISSION
Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) has a three-tier • To accelerate the process of preparation, certification and
structure comprising of the General Body of 19 members, distribution of IP Reference Substances, including the
Governing Body of 8-10 members and Scientific Body of 15-23 related substances, impurities and degradation products.
members from different related scientific fields; the number of • To collaborate with pharmacopoeias like the Ph Eur, BP,
members of the Scientific Body may vary from time to time. USP, JP, ChP and International Pharmacopoeia with a view
The Secretary, Ministry of Health and Family Welfare, is the to harmonizing with global standards
Chairman and the the Chairman-Scientific Body is the Co-
• To review existing monographs periodically with a view
Chairman of the Commission.
to deleting obsolete ones and amending those requiring
upgradation / revision.
• To organize educational programs and research activities
for spreading and establishing awareness on the need
and scope of quality standards for drugs and related
articles / materials.
The Governing Body
IPC-Structure
The composition of the Governing Body is given below:
The primary responsibility of the Scientific Body is to provide Chairman The Secretary (Health & Family Welfare)
guidlines for Standards development related to the Indian Government of India
Pharmacopoeia with assistance of its Expert Committees. Ministry of Health & Family Welfare
Nirman Bhawan
The Indian Pharmacopoeia is published in continuing pursuit
New Delhi-110 011.
of the Mission, Vision and Objectives of the IPC.
(Mr. Prasanna Hota until 30 October 2006
Mission
Mr. Naresh Dayal from 31 October 2007 )
To promote public health in India by bringing out authoritative Co-Chairman Dr. Nitya Anand
and officially accepted standard for quality of drugs including Ex-Director
active pharmaceutical ingredients, excipients and dosage Central Drug Research Institute
forms, used by health professionals, patients and consumers. B-62, Nirala Nagar
Lucknow-226 020.
Vision
Member The Additional Secretary & Finance Advisor
To promote the highest standards of drugs for use in humans
Ministry of Health & Family Welfare
and animals within practical limits of the technologies available
Nirman Bhawan
for manufacture and analysis.
New Delhi -110 011.
Objectives (Dr. Sanjiv Misra until 30 April 2006
Mr. Raghubir Singh from 30 May 2006)
• To develop comprehensive monographs for drugs to be
included in the Indian Pharmacopoeia, including active Invitee The Additional Secretary
pharmaceutical ingredients, pharmaceutical aids and Ministry of Health & Family Welfare
dosage forms as well as medical devices, and to keep Nirman Bhawan
them updated by revision on a regular basis. New Delhi-110 011.
• To develop monographs for herbal drugs, both raw drugs (Mr. Deepak Gupta)
and extracts/formulations therefrom.
Member The Joint Secretary (Drugs)
• To accord priority to monographs of drugs included in Ministry of Health & Family Welfare,
the National Essential Drugs List and their dosage forms. Nirman Bhawan
• To take note of the different levels of sophistication in New Delhi-110 011.
analytical testing/ instrumentation available while framing (Ms. Rita Teaotia until February 2007
the monographs. Mr. Debasish Panda from 2 April 2007 )
ix
INDIAN PHARMACOPOEIA COMMISSION IP 2007
Member The Drugs Controller General (I), Member The Joint Secretary (Drugs)
Directorate General of Health Services Ministry of Health & Family Welfare
Ministry of Health & Family Welfare Nirman Bhawan, New Delhi.
Nirman Bhawan
(Ms. Rita Teaotia until February 2007
New Delhi-110 011.
Mr. Debasish Panda from 2 April 2007 )
(Mr. Ashwini Kumar until 31 August 2006
Member The Drugs Controller General (I)
Dr M. Venkateswarlu from 1 September 2006)
Directorate General of Health Services
Member The Director (Drugs) Nirman Bhawan, New Delhi.
Ministry of Health & Family Welfare
(Mr. Ashwini Kumar until 31 August 2006
Nirman Bhawan
Dr. M. Venkateswarlu from 1 September2006)
New Delhi-110 011.
Member The Director
(Mr. Rajesh Bhushan until 12 December 2006
National Institute of Biologicals
Dr. Asha Thomas from January 2007)
B-62, Institutional Area
Member The Director Noida-201 307
National Institute of Biologicals
(Dr. V. K. Kashyap)
B-62, Institutional Area
Noida-201 307 Member The Director
(Dr. V. K. Kashyap) Central Drugs Laboratory
3, Kyd Street
Invitee Dr. P. R. Pabrai
Kolkata
Ex-Director, Central Indian Pharmacopoeia
(Dr. P. K. Chatterjee until December 2005)
Laboratory,
C-568, Sarita Vihar Member The Joint Drugs Controller
New Delhi-110 076 North Zone
Ghaziabad (U.P.)
Member The Director
(Dr. S. R. Gupta until 30 September 2005
Secretary Central Indian Pharmacopoeia Laboratory
(Mr. N.C. Dhawan from 12 July 2007)
Sector-23, Rajnagar
Ghaziabad-201 002 Member The Director-Professor
(Dr. G. N. Singh) Department of Pharmacology
Jawaharlal Institute of Post graduate Medical
The General Body Education and Research
Pondicherry-605 006.
The composition of the General Body is as follows:
(Dr. C. Adithan)
Chairman The Secretary (Health & Family Welfare)
Member Commissioners in charge of Drug Control
Government of India
Administration, Andhra Pradesh
Ministry of Health & Family Welfare
Nirman Bhawan (Mr. Ranga Rao)
New Delhi-110 011.
Member Commissioners in charge of Drug Control
(Mr. Prasanna Hota until 30 October 2006 Administration, Maharashtra
Mr. Naresh Dayal from 31 October 2007 )
(Mr. A. Ram Krishnan)
Member Dr. Nitya Anand
Member Commissioners in charge of Drug Control
Ex-Director, Central Drug Research Institute
Administration, Gujarat
B-62, Nirala Nagar
(Dr S.P. Adeshara)
Lucknow-226 020.
Member Commissioners in charge of Drug Control
Member The Additional Secretary & Finance Advisor,
Administration, Uttar Pradesh
Ministry of Health & Family Welfare
(Mr. Satguru Prasad)
Nirman Bhawan
New Delhi 110 011. Member Commissioners in charge of Drug Control
(Dr. Sanjiv Misra until 30 April 2006 Administration, Orissa
Mr. Raghubir Singh from 30 May 2006) (Mr. B. C. Panda)
x
IP 2007 INDIAN PHARMACOPOEIA COMMISSION
Member The Director Member Professor V. K. Kapoor
National Institute of Pharmaceutical Education Ex-Dean and Chairman, Pharmaceutical
and Research (NIPER) Sciences, Punjab University
Sector 67, SAS Nagar 1743, Pushpae Complex
Mohali-160 062. Sector 49 B
(Professor P. Rama Rao) Chandigarh-160 047
Member The President Member Professor P. Rama Rao
Indian Drug Manufacturer Association Director
(IDMA) National Institute of Pharmaceutical Education
102-B, Poonam Chambers, ‘A’ Wing’ and Research (NIPER)
Dr. Annie Besant Road, Worli Sector 67, SAS Nagar
Mumbai – 400018 Mohali-160 062.
(Mr. Suresh G. Kare) Member Mr. Parthajyoti Gogoi
Director-in-Charge
Member The President
Regional Drugs Testing Laboratory (RDTL)
Organizational of Pharmaceutical Producer of
Khana Para, Panjabari, Six mile
India (OPPI)
Guwahati-781 037.
(Shri Ranjit Sahani)
Member Professor Saranjit Singh
Member The President
Professor and Head
Association of Manufacturers of Ayurvedic
Department of Pharmaceutical Analysis
Medicines
National Institute of Pharmaceutical Education
(Mr. P. M. Shroff)
and Research (NIPER)
Member The Director Sector 67, SAS Nagar
Secretary Central Indian Pharmacopoeia Laboratory Mohali-160 002.
Sector-23, Rajnagar
Member Dr. V. A. Srinivasan
Ghaziabad-201 002
Research Director
(Dr. G. N. Singh)
Indian Immunologicals Ltd.
Gachibowli Post
Hyderabad-500 032.
The Scientific Body
Member Dr. Prem K. Gupta
The list below includes those members who served during the
Ex-Drugs Controller (I)
period
ouse No. 95 DDA Flats
Chairman Dr. Nitya Anand
Pocket ‘B’, Sukhdev Vihar
Ex-Director
New Delhi -110 025.
Central Drug Research Institute
B-62, Nirala Nagar Member Dr. S. N. Pal
Lucknow-226 020 Executive Director
HSCC
Vice-Chairman Dr. P. R. Pabrai
E-6(A), Sector-1,
Ex-Director, Central Indian Pharmacopoeia
Noida -201 301
Laboratory,
C-568, Sarita Vihar Member Dr. D. B. Anantha Narayana
New Delhi-110 076 Head, Herbal Research
Hindustan Lever Research Centre
Member Mr. R. S. Iyer
Unilever Research India
M.S.H. Layout, II Stage
64, Main Road, Whitefiled
Anand Nagar
Bangalore- 560 066.
Bangalore-560 024.
Member Mr. J. L. Sipahimalani Member Mr. Prafull D. Sheth
10-C, Ananta, R. Patel Lane E-256, Greater Kailash-I
Mumbai-400 026 New Delhi-110 048.
xi
INDIAN PHARMACOPOEIA COMMISSION IP 2007
Member Dr. V. K. Lal Member Professor Y. K. Gupta
College of Pharmacy, Head, Department of Pharmacology,
Institute of Foreign Trade and Management All India Institute of Medical Sciences
Lodhipur-Rajput Ansari Nagar
Delhi-Moradabad Raod New Delhi.
Moradabad. U.P.
Invitee Mr.Gidy Asrani
Member Dr. Anil Paul Kariath President, Pharmacon,
President – Consulting & Training 3, Salmona Ville, North Avenue,
Bangalore Biotech Labs. Pvt. Ltd. Santa Cruze,
#49/2, Gubbi Cross, Off Hennur Cross Mumbai-400 054.
Bangalore-560 077.
Invitee Dr. Manish Gangrade
Member Dr. P. G. Shrotriya Head - Analytical Development Lab.
Chief Executive, Elite Pharma Consultants CIPLA Limited
11/302 Sea Woods, NRI Complex, Nerul Mumbai
Navi Mumbai-400 706.
Member Dr. G. N. Singh
Member Dr. Vinay G. Nayak Secretary Director
President, Tech. Operations Central Indian Pharmacopoeia Laboratory
Watson Pharma Pvt. Ltd. Sector-23, Rajnagar
Mumbai. Ghaziabad-201 002
Member Mr. Vinod Arora
Vice-President (Pharma Research)
Ranbaxy Research Laboratories Executive Committee
Plot No. 20, Sector 18, Udyog Vihar
Dr Nitya Anand, Dr. M Venkateswarlu*, Mr. P. D. Sheth, Mr. R.
Industrial Area,
S. Iyer and Dr. G. N. Singh.
Gurgaon-122 001.
*(Mr. Ashwini Kumar until 31 August 2006
Member Dr. T. G. Chandrashekhar Dr M. Venkateswarlu from 1 September 2006)
Vice-President, Global Quality & Analytical
Research,
Ranbaxy Research Laboratories, Expert Committees
Plot No. 20, Sector 18, Udyog Vihar
Expert Committee on Anti-Retroviral Drugs
Industrial Area
Gurgaon-122 001 Dr. T. G. Chandrashekhar (Chair), Dr. K. M. Thomas, Mr.
Antony Raj Gomes, Dr. S. Raghuveer, Dr. Pramod Dalvi, Dr.
Member Dr. K. M. Thomas
Manish Gangrade.
T C/ 10 /1013
CO-OP-Housing Gardens, Expert Committee on Anti-Tuberculosis/Anti Asthma Drugs
Mannamoola, Peroorkada P O Dr. Vinay G Nayak (Chair), Professor Saranjit Singh, Dr. Amarjit
Thiruvananthapuram Singh, Mr. Satyawan Hatte.
Kerala-695005.
Expert Committee on Bioassay, Biostatistics and Toxicology
Member Dr. Hemnalini Kumar
Professor P. Rama Rao (Chair), Dr. Prakash V. Diwan, Dr. K. M.
Director, Bio-Products
Chacko.
Salesworth India Ltd.
713 Syndicate Bank Road Expert Committee on Biotechnological and Recombinant
Indira Nagar I Stage DNA Technology Products
Bangalore-560 038
Dr. Anil Paul Kariath (Chair), Mr. Ganesh Kumaraj, Mr. S. V.
Member Dr. Anoop Misra Kotbagi, Dr. Rustom Mody, Dr. Venkata Ramana.
Former Professor
Expert Committee on Blood and Blood Products
All India Institute of Medical Sciences
Ansari Nagar Dr. Prem K. Gupta (Chair), Mr. R. Narayana Swamy, Dr. Zareen
New Delhi. Bharucha, Dr. Kabita Chatterjee, Mr. Atul Kr. Nasa.
xii
IP 2007 INDIAN PHARMACOPOEIA COMMISSION
Expert Committee on Clinical Medicine and Pharmacology Professor Roop K. Khar, Dr. Praful R. Naik.
Professor Y. K. Gupta (Chair), Dr. Anoop Misra, Professor P. Expert Committee on Publication and Information Technology
Rama Rao, Dr. Rama Mukherjee, Dr. R. R. Kasliwal
Dr. Hemnalini Kumar (Chair), Mr. Parthajyoti Gogoi, Dr. D. B.
Expert Committee on Compounding Pharmacy and Website Anantha Narayana, Mr. Daara B. Patel, Dr. Sanjay Singh.
Mr. Parthajyoti Gogoi (Chair), Professor Y. Madhusudan Rao, Expert Committee on Vaccines and Other Biological Products
Dr. Prakash V. Diwan, Dr. A. Ramkishan, Dr. R. Sweety Prem
Dr. V. A. Srinivasan (Chair), Dr. A. K. Tahlan, Dr. Surinder
Kumar.
Singh, Dr. Rishendra Verma, Dr. S. S. Jadhav.
Expert Committee on Devices and Diagnostics
Dr. S. N. Pal (Chair), Professor Alok Ray, Dr. G. S. IPC Secretariat
Bhuvaneshwar, Sh. M. Mitra.
An active and effective support to the Expert Committees is
Expert Committee on Drug Nomenclature provided by the following staff members from CIPL.
Professor V. K. Kapoor (Chair), Dr. (Mrs.) Dr Hardeep Wadhwa, Director CIPL
Professor Yatendra Kumar.
Dr. G. N. Singh Secretary-cum-Scientific Director
Expert Committee on General Analytical Methods Research & Development Division
Dr. T. G. Chandrashekhar (Chair), Professor Saranjit Singh, The major activities related to formatting, reviewing and
Professor Y. K. Agrawal, Dr. K. M. Thomas, Dr. Milind Joshi. liasons for Standard Development is performed by following:
Expert Committee on General Policies and Planning Dr. Raman Mohan Singh (Head), Dr. S. C. Mathur, Mr. Dinesh
Kr. Sharma, Mr. Pawan Kr. Saini, Mr. Munendra Kr. Poonia and
Mr. Prafull D. Sheth (Chair), Mr. B. N. Thakore, Dr. Shailesh
Km. Anu Somvanshi.
Nagarsenker, Professor Y. Madhusudan Rao, Mr. B. K. Sharma.
Pharmacology & Microbiology Division
Expert Committee on General Chapters and General Format
The matters related to biologicals is taken care of by following:
Mr. R. S. Iyer (Chair) .
Dr. Jai Prakash (Head), Mr. Surendra Kr. Talwar, Mr. Charan
Expert Committee on Herbal Products and Crude Drugs
Singh Nivoria, Mr. Alok Sharma, Mr. Manoj Kr. Pandey and
Dr. D. B. Anantha Narayana (Chair), Dr. S. S. Handa, Dr. G. S. Mr. Satyapal Singh.
Lavekar, Dr. V. K. Lal, Dr. C. K. Katiyar, Dr. Amit Agarwal
Publication Division
Expert Committee on IP Reference Substances
The issues related to publication, sales and marketing is
Dr. M Venkateswarlu (Chair), Dr. P. R. Pabrai, Professor Saranjit looked after by following:
Singh.
Mr. K. K. Singh (Head), Mr. Udai Pal and Mr. Sudhakar Singh.
Expert Committee on Medicinal Chemicals I
Scientific, Administrative and Miscellaneous Support
Dr. P. R. Pabrai (Chair), Dr. R. A. Singh, Dr. N. Murugesan, Dr.
Support provided in Scientific and Administrative matters by
K. K. Chakraborti, Dr. Ashok Panwar.
following is appreciable:
Expert Committee on Medicinal Chemicals II
Mrs. Savita Shukala, Ms. Sangeeta Bhatnagar and
Professor V. K. Kapoor (Chair), Professor Meenakshi Bajpai. Mr. Satyaprakash Tyagi
Expert Committee on Medicinal Chemicals III Mr. R. C. Saxena, Mr. Tribhuvan Nautiyal, Mr. I. J. S. Oberoi
and Mr. H. S. Rana.
Mr. J. L. Sipahimalani (Chair), Ms Rashida Najmi,
Dr. Prashant Dikshit, Ms V. R. Menon.
Other Participants
Expert Committee on Parenteral Products
Participants other than those mentioned above who assisted
Dr. P. G. Shrotriya (Chair), Mr. Sanjit Singh Lamba,
in the work relating to preparation of this Pharmacopoeia are
Dr. Sumant Baukhandi, Mr. G. S. Bedi, Mr. Satish. R. Kulkarni.
given below:
Expert Committee on Pharmaceutical Dosage Forms
Dr. Abraham Patani, Dr. A. K. Singh, Mr. Arvind Kukrety, Dr.
Mr. Vinod Arora (Chair), Professor Arvind K Bansal, A. Ram Krishan, Mrs. Annie Pillai, Mr. Arun Mendiratta, Mr.
Dr Kona Subrahmanya Srinivas, Dr. Kisan B. Chaudhari, Arun Khosla, Mr. Atul Kumar Sharma, Ms. Ayesha Patial, Dr.
xiii